JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M204658200 on June 12, 2002

J. Biol. Chem., Vol. 277, Issue 35, 32078-32085, August 30, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/35/32078    most recent
M204658200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prisco, M.
Right arrow Articles by Baserga, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prisco, M.
Right arrow Articles by Baserga, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nuclear Translocation of Insulin Receptor Substrate-1 by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like Growth Factor Receptor*

Marco Prisco, Francesca Santini, Raffaele Baffa, Mingli Liu, Robert Drakas, An Wu, and Renato BasergaDagger

From the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

32D cells are a murine hemopoietic cell line that undergoes apoptosis upon withdrawal of interleukin-3 (IL-3) from the medium. 32D cells have low levels of the type 1 insulin-like growth factor (IGF-I) receptor and do not express insulin receptor substrate-1 (IRS-1) or IRS-2. Ectopic expression of IRS-1 delays apoptosis but cannot rescue 32D cells from IL-3 dependence. In 32D/IRS-1 cells, IRS-1 is detectable, as expected, in the cytosol/membrane compartment. The SV40 large T antigen is a nuclear protein that, by itself, also fails to protect 32D cells from apoptosis. Co-expression of IRS-1 with the SV40 T antigen in 32D cells results in nuclear translocation of IRS-1 and survival after IL-3 withdrawal. Expression of a human IGF-I receptor in 32D/IRS-1 cells also results in nuclear translocation of IRS-1 and IL-3 independence. The phosphotyrosine-binding domain, but not the pleckstrin domain, is necessary for IRS-1 nuclear translocation. Nuclear translocation of IRS-1 was confirmed in mouse embryo fibroblasts. These results suggest possible new roles for nuclear IRS-1 in IGF-I-mediated growth and anti-apoptotic signaling.

* This work was supported by Grants CA089640 and AG20956 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Kimmel Cancer Center, Thomas Jefferson University, 233 S. 10th St., 624 BLSB, Philadelphia, PA 19107. Tel.: 215-503-4507; Fax: 215-923-0249; E-mail: R_baserga@lac.jci.tju.edu.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
H. Jo, Y. Jia, K. K. Subramanian, H. Hattori, and H. R. Luo
Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
Mol. Cell. Biol., July 1, 2008; 28(13): 4285 - 4299.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Yu and J. C. Alwine
Interaction between Simian Virus 40 Large T Antigen and Insulin Receptor Substrate 1 Is Disrupted by the K1 Mutation, Resulting in the Loss of Large T Antigen-Mediated Phosphorylation of Akt
J. Virol., May 1, 2008; 82(9): 4521 - 4526.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
D. Sisci, C. Morelli, C. Garofalo, F. Romeo, L. Morabito, F. Casaburi, E. Middea, S. Cascio, E. Brunelli, S. Ando, et al.
Expression of nuclear insulin receptor substrate 1 in breast cancer
J. Clin. Pathol., June 1, 2007; 60(6): 633 - 641.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga
Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells
Cancer Res., March 1, 2007; 67(5): 2124 - 2130.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Sun, X. Tu, and R. Baserga
A Mechanism for Cell Size Regulation by the Insulin and Insulin-Like Growth Factor-I Receptors
Cancer Res., December 1, 2006; 66(23): 11106 - 11109.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Chen, A. Wu, H. Sun, R. Drakas, C. Garofalo, S. Cascio, E. Surmacz, and R. Baserga
Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and {beta}-Catenin
J. Biol. Chem., August 19, 2005; 280(33): 29912 - 29920.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M Koda, M Sulkowska, L Kanczuga-Koda, and S Sulkowski
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases
J. Clin. Pathol., June 1, 2005; 58(6): 645 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Wu, X. Tu, M. Prisco, and R. Baserga
Regulation of Upstream Binding Factor 1 Activity by Insulin-like Growth Factor I Receptor Signaling
J. Biol. Chem., January 28, 2005; 280(4): 2863 - 2872.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Sun and R. Baserga
Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells
Endocrinology, November 1, 2004; 145(11): 5332 - 5343.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Prisco, A. Maiorana, C. Guerzoni, G. Calin, B. Calabretta, R. Voit, I. Grummt, and R. Baserga
Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells
Mol. Cell. Biol., June 15, 2004; 24(12): 5421 - 5433.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Sciacca, M. Prisco, A. Wu, A. Belfiore, R. Vigneri, and R. Baserga
Signaling Differences from the A and B Isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1
Endocrinology, June 1, 2003; 144(6): 2650 - 2658.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. V. Lee, P. Zhang, M. Ivanova, S. Bonnette, S. Oesterreich, J. M. Rosen, S. Grimm, R. C. Hovey, B. K. Vonderhaar, C. R. Kahn, et al.
Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland
Endocrinology, June 1, 2003; 144(6): 2683 - 2694.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Sun, X. Tu, M. Prisco, A. Wu, I. Casiburi, and R. Baserga
Insulin-Like Growth Factor I Receptor Signaling and Nuclear Translocation of Insulin Receptor Substrates 1 and 2
Mol. Endocrinol., March 1, 2003; 17(3): 472 - 486.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.